2024 Annual Meeting | C81 - Headache in Special Populations

Date Monday 04/15/24

Time 01:00 PM - 03:00 PM MDT Add To Calendar

Location Colorado Convention Center | 102/104/106

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Larry Charleston IV, MD, MSc, FAHS

Topic(s) Headache

Learning Objectives Participants should be able to describe, and define when appropriate, special populations in headache medicine; discuss key epidemiology of special populations in headache medicine; and define intersectionality and articulate its importance in the care of special populations.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:15 PM MDT	Introduction	Headache in Special Populations Larry Charleston IV, MD, MSc, FAHS
01:15 PM - 01:30 PM MDT	Speaker	Case & Presentation: Headache Special Population—Individuals with Severe Cognitive, Mental, and/or Physical Impairments and the Caregiver Susan M. Woolner, CPXP
01:30 PM - 01:35 PM MDT	Q&A	Questions & Answers Susan M. Woolner, CPXP
01:35 PM - 01:50 PM MDT	Speaker	Case & Presentation: Headache Special Population: Children Christina L. Szperka, MD
01:50 PM - 01:55 PM MDT	Q&A	Questions & Answers Christina L. Szperka, MD
01:55 PM - 02:10 PM MDT	Speaker	Case & Presentation: Headache Special Population: Rural Populations David B. Watson, MD, FAAN
02:10 PM - 02:15 PM MDT	Q&A	Questions & Answers David B. Watson, MD, FAAN
02:15 PM - 02:25 PM MDT	Q&A	Panelists Questions & Answers Larry Charleston IV, MD, MSc, FAHS, Susan M. Woolner, CPXP, David B. Watson, MD, FAAN
02:25 PM - 02:35 PM MDT	Speaker	A Brief Exploration of Intersectionality Larry Charleston IV, MD, MSc, FAHS
02:35 PM - 02:55 PM MDT	Discussion	Final Case Presentation with Audience Participation and Panelist Discussion Larry Charleston IV, MD, MSc, FAHS, Susan M. Woolner, CPXP, David B. Watson, MD, FAAN
02:55 PM - 03:00 PM MDT	Closing Remarks	Closing Remarks Larry Charleston IV, MD, MSc, FAHS

Faculty Disclosures
Larry Charleston IV, MD, MSc, FAHS	Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/AbbVie. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven Biopharmaceuticals. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LinPharma. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Charleston has a non-compensated relationship as a Associate Editor with Headache Journal: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member at Large with Alliance for Headache Disorders Advocacy that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member with Clinical Neurological Society of America that is relevant to AAN interests or activities.
Susan M. Woolner, CPXP	Ms. Woolner has nothing to disclose.
David B. Watson, MD, FAAN	Dr. Watson has nothing to disclose.
Christina L. Szperka, MD	The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher Smith. The institution of Dr. Szperka has received research support from NINDS. The institution of Dr. Szperka has received research support from PCORI. The institution of Dr. Szperka has received research support from International Headache Society.